BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23691974)

  • 1. Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis.
    Lin Y; Wei C; Liu Y; Qiu Y; Liu C; Guo F
    Cancer Sci; 2013 Sep; 104(9):1217-25. PubMed ID: 23691974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the anti-cervical cancer effect of a prodrug :CBZ-AAN-DOX with hypoxic cell culture and tumor-bearing zebrafish models.
    Chen HC; Rui W; You SY; Liu XW; Huang J; Chen HY
    Exp Cell Res; 2020 Jun; 391(1):111980. PubMed ID: 32229193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis.
    Zonneville J; Colligan S; Grant S; Miller A; Wallace P; Abrams SI; Bakin AV
    Int J Cancer; 2020 Oct; 147(8):2279-2292. PubMed ID: 32452014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.
    Liu C; Sun C; Huang H; Janda K; Edgington T
    Cancer Res; 2003 Jun; 63(11):2957-64. PubMed ID: 12782603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.
    Wu W; Luo Y; Sun C; Liu Y; Kuo P; Varga J; Xiang R; Reisfeld R; Janda KD; Edgington TS; Liu C
    Cancer Res; 2006 Jan; 66(2):970-80. PubMed ID: 16424032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
    Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
    Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.
    Rolny C; Mazzone M; Tugues S; Laoui D; Johansson I; Coulon C; Squadrito ML; Segura I; Li X; Knevels E; Costa S; Vinckier S; Dresselaer T; Åkerud P; De Mol M; Salomäki H; Phillipson M; Wyns S; Larsson E; Buysschaert I; Botling J; Himmelreich U; Van Ginderachter JA; De Palma M; Dewerchin M; Claesson-Welsh L; Carmeliet P
    Cancer Cell; 2011 Jan; 19(1):31-44. PubMed ID: 21215706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
    Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies.
    Chen P; Bonaldo P
    Int Rev Cell Mol Biol; 2013; 301():1-35. PubMed ID: 23317816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity.
    Liao D; Liu Z; Wrasidlo W; Chen T; Luo Y; Xiang R; Reisfeld RA
    Nanomedicine; 2011 Dec; 7(6):665-73. PubMed ID: 21419870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.
    Liu Y; Bajjuri KM; Liu C; Sinha SC
    Mol Pharm; 2012 Jan; 9(1):168-75. PubMed ID: 22044266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumor-associated macrophage in tumor progression.
    Fukuda K; Kobayashi A; Watabe K
    Front Biosci (Schol Ed); 2012 Jan; 4(2):787-98. PubMed ID: 22202090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity.
    Devy L; de Groot FM; Blacher S; Hajitou A; Beusker PH; Scheeren HW; Foidart JM; Noël A
    FASEB J; 2004 Mar; 18(3):565-7. PubMed ID: 14734647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer.
    Curtis VF; Wang H; Yang P; McLendon RE; Li X; Zhou QY; Wang XF
    PLoS One; 2013; 8(1):e54916. PubMed ID: 23372791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of a CBZ-AAN-Dox Prodrug and its in vitro Effects on SiHa Cervical Cancer Cells Under Hypoxic Conditions.
    Chen H; Liu X; Clayman ES; Shao F; Xiao M; Tian X; Fu W; Zhang C; Ruan B; Zhou P; Liu Z; Wang Y; Rui W
    Chem Biol Drug Des; 2015 Oct; 86(4):589-98. PubMed ID: 25619622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.
    Chen M; Lei X; Shi C; Huang M; Li X; Wu B; Li Z; Han W; Du B; Hu J; Nie Q; Mai W; Ma N; Xu N; Zhang X; Fan C; Hong A; Xia M; Luo L; Ma A; Li H; Yu Q; Chen H; Zhang D; Ye W
    J Clin Invest; 2017 Oct; 127(10):3689-3701. PubMed ID: 28846068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma.
    Shen L; Li H; Shi Y; Wang D; Gong J; Xun J; Zhou S; Xiang R; Tan X
    Sci Rep; 2016 Jul; 6():30347. PubMed ID: 27464733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenesis targeting tumor microenvironment synergizes glucuronide prodrug antitumor activity.
    Juan TY; Roffler SR; Hou HS; Huang SM; Chen KC; Leu YL; Prijovich ZM; Yu CP; Wu CC; Sun GH; Cha TL
    Clin Cancer Res; 2009 Jul; 15(14):4600-11. PubMed ID: 19584154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
    Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
    Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis.
    Dondossola E; Rangel R; Guzman-Rojas L; Barbu EM; Hosoya H; St John LS; Molldrem JJ; Corti A; Sidman RL; Arap W; Pasqualini R
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20717-22. PubMed ID: 24297924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.